Literature DB >> 2923375

Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs.

A Pettenazzo1, A Jobe, M Ikegami, R Abra, E Hogue, P Mihalko.   

Abstract

Rabbits were given by tracheal instillation liposomes, liposomes carrying metaproterenol sulfate (MPS) and suspended in a MPS solution, rabbit surfactant, or rabbit surfactant suspended in a MPS solution. The lipid suspensions were labeled with [14C]cholesterol and [3H]phosphatidylcholine. The percent recoveries of the labels were measured over 24 h in alveolar wash, lung tissue after alveolar wash, and the total lungs. All clearance curves for both phosphatidylcholine and cholesterol from liposomes were the same in the presence or absence of MPS. Alveolar clearance curves for both labels from rabbit surfactant were the same; however, the surfactant-associated labels were cleared to the lung tissue more rapidly than were the liposome-derived labels. Despite different alveolar clearance curves, all clearance curves for cholesterol from the total lungs were similar at a rate of 20 to 30%/24 h of the injected labeled cholesterol. Phosphatidylcholine was cleared from the total lungs more rapidly, at rates from 35 to 56%/24 h. Although MPS did not change labeled liposomal lipid clearance, the beta-agonist increased surfactant lipid clearance. The different responses to beta-agonist and the different alveolar clearance curves indicated distinct alveolar-to-lung tissue metabolism for liposomal versus surfactant phosphatidylcholine and cholesterol, although overall lung clearance rates were similar.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923375     DOI: 10.1164/ajrccm/139.3.752

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Authors:  Elke Kleemann; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Thomas Kissel; Werner Seeger
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

2.  Nebulization of liposomes. I. Effects of lipid composition.

Authors:  R W Niven; H Schreier
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

3.  Turnover of cholesterol and dipalmitoyl phosphatidylcholine in surfactant of adult rat lung.

Authors:  M E Jones; H A Barr; T E Nicholas
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

4.  Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis.

Authors:  Y Rojanasakul; L Y Wang; C J Malanga; J K Ma; J Liaw
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

5.  Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.

Authors:  J P Wong; L L Stadnyk; E G Saravolac
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

6.  The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury.

Authors:  Scott Milos; Joshua Qua Hiansen; Brandon Banaschewski; Yi Y Zuo; Li-Juan Yao; Lynda A McCaig; James Lewis; Cory M Yamashita; Ruud A W Veldhuizen
Journal:  Biochem Biophys Rep       Date:  2016-06-08

7.  Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1.

Authors:  E G Saravolac; B Kournikakis; L Gorton; J P Wong
Journal:  Antiviral Res       Date:  1996-03       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.